Open access · CC-BY
via OpenAlex
Brain-Gut-Microbiota Axis in Alzheimer’s Disease
Journal of Neurogastroenterology and Motility · 2019 · ▲ 823 citations
Abstract
Disturbances along the brain-gut-microbiota axis may significantly contribute to the pathogenesis of neurodegenerative disorders. Alzheimer's disease (AD) is the most frequent cause of dementia characterized by a progressive decline in cognitive function associated with the formation of amyloid beta (Aβ) plaques and neurofibrillary tangles. Alterations in the gut microbiota composition induce increased permeability of the gut barrier and immune activation leading to systemic inflammation, which in turn may impair the blood-brain barrier and promote neuroinflammation, neural injury, and ultimately neurodegeneration. Recently, Aβ has also been recognized as an antimicrobial peptide participating in the innate immune response. However, in the dysregulated state, Aβ may reveal harmful properties. Importantly, bacterial amyloids through molecular mimicry may elicit cross-seeding of misfolding and induce microglial priming. The Aβ seeding and propagation may occur at different levels of the brain-gut-microbiota axis. The potential mechanisms of amyloid spreading include neuron-to-neuron or distal neuron spreading, direct blood-brain barrier crossing or via other cells as astrocytes, fibroblasts, microglia, and immune system cells. A growing body of experimental and clinical data confirms a key role of gut dysbiosis and gut microbiota-host interactions in neurodegeneration. The convergence of gut-derived inflammatory response together with aging and poor diet in the elderly contribute to the pathogenesis of AD. Modification of the gut microbiota composition by food-based therapy or by probiotic supplementation may create new preventive and therapeutic options in AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5056/jnm18087
- Canonical
- link ↗
- Fetched
- 2026-09-18 MST
Cite this
APA
Kowalski, K., & Mulak, A. (2019). Brain-Gut-Microbiota Axis in Alzheimer’s Disease. <em>Journal of Neurogastroenterology and Motility</em>. https://doi.org/10.5056/jnm18087
Vancouver
Kowalski K, Mulak A. Brain-Gut-Microbiota Axis in Alzheimer’s Disease. Journal of Neurogastroenterology and Motility. 2019. doi:10.5056/jnm18087.
BibTeX
@article{karol2019BrainG,
title = {Brain-Gut-Microbiota Axis in Alzheimer’s Disease},
author = {Karol Kowalski and Agata Mulak},
journal = {Journal of Neurogastroenterology and Motility},
year = {2019},
doi = {10.5056/jnm18087},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
World Journal of Cardiology 2020
Open access · CC-BY
Role of gut microbiota in cardiovascular diseases
Frontiers in Cellular Neuroscience 2021
Open access · CC-BY
Sirtuins as Potential Therapeutic Targets for Mitigating Neuroinflammation Associated With Alzheimer’s Disease
Brain 2021
Open access · OA
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
International Journal of Cancer 2021
Citation only
DNA methylation age as a biomarker for cancer
Nutrients 2026
Open access · OA
Targeting the Gut Microbiome in Cardiovascular Disease: Current Therapeutic Strategies and Future Perspectives.
Nutrients 2026
Citation only